Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -6.09%1.08B | 4.09%2.17B | 7.82%1.15B | 82.72%2.09B | 71.20%1.07B | -28.91%1.14B | -30.35%622.63M | 17.25%1.61B | 46.92%893.98M | -13.12%1.37B |
| Operating income | -6.09%1.08B | 4.09%2.17B | 7.82%1.15B | 82.72%2.09B | 71.20%1.07B | -28.91%1.14B | -30.35%622.63M | 17.25%1.61B | 46.92%893.98M | -13.12%1.37B |
| Operating expenses | -5.55%-1.05B | 1.24%-2.02B | -1.99%-991.11M | -82.34%-2.05B | -87.38%-971.82M | -28.84%-1.12B | -29.93%-518.64M | -28.83%-871.44M | -23.39%-399.16M | 6.16%-676.43M |
| Gross profit | -79.01%33.2M | 288.00%149.17M | 68.03%158.17M | 105.41%38.45M | -9.49%94.13M | -97.45%18.72M | -78.98%104M | 5.94%734.27M | 73.62%494.83M | -18.98%693.1M |
| Selling expenses | -18.49%-1.61M | -6.32%-3.73M | 23.48%-1.36M | -43.45%-3.51M | 16.65%-1.78M | 54.80%-2.45M | 13.38%-2.13M | 35.11%-5.41M | -31.85%-2.46M | -36.57%-8.34M |
| Administrative expenses | -10.61%-52.63M | 8.90%-108.46M | -16.01%-47.58M | -44.38%-119.05M | -15.66%-41.01M | 27.97%-82.45M | 21.25%-35.46M | -36.29%-114.46M | -24.39%-45.03M | -16.33%-83.98M |
| Profit from asset sales | 2,877.78%2K | ---- | -100.01%-72 | 430.99%1.27M | 402.24%726.61K | 46.16%-383.78K | -1.61%-240.41K | 19.38%-712.88K | -231.98%-236.59K | -125.97%-884.23K |
| Revaluation surplus | 21.39%-3.32M | 135.02%2.6M | 13.18%-4.22M | -613.83%-7.41M | 9.88%-4.86M | 307.52%1.44M | ---5.39M | ---695.04K | ---- | ---- |
| -Changes in the fair value of other assets | 21.39%-3.32M | 135.02%2.6M | 13.18%-4.22M | -613.83%-7.41M | 9.88%-4.86M | 307.52%1.44M | ---5.39M | ---695.04K | ---- | ---- |
| Impairment and provision | 84.04%-2.24M | -82.86%10.06M | 8.87%-14.01M | 586.22%58.7M | -858.51%-15.38M | -107.54%-12.07M | 82.77%-1.6M | 131.91%160.17M | 82.61%-9.31M | -22,735.70%-501.88M |
| -Other impairment is provision | 84.04%-2.24M | -82.86%10.06M | 8.87%-14.01M | 586.22%58.7M | -858.51%-15.38M | -107.54%-12.07M | 82.77%-1.6M | 131.91%160.17M | 82.61%-9.31M | -22,735.70%-501.88M |
| Special items of operating profit | 811.70%41.51M | 46.94%31.68M | -184.17%-5.83M | 26.97%21.56M | -80.07%6.93M | 396.29%16.98M | 303.44%34.76M | 99.58%-5.73M | 112.99%8.62M | -13,800.87%-1.37B |
| Operating profit | -134.50%-18.27M | 125.28%17.99M | 933.08%52.96M | 45.93%-71.14M | -91.18%5.13M | -117.81%-131.58M | -86.52%58.1M | 157.36%738.66M | 256.28%431.15M | -269.92%-1.29B |
| Financing cost | 8.14%-57.57M | 1.10%-134.25M | 16.73%-62.67M | -53.99%-135.75M | -55.54%-75.27M | -312.40%-88.15M | -136.31%-48.39M | -48.68%-21.38M | -168.57%-20.48M | -202.39%-14.38M |
| Adjustment items of earning before tax | 102.80%7.63M | -15,218.80%-284.94M | -54,906.81%-272.15M | 88.90%-1.86M | 102.91%496.56K | -2,981.14%-16.76M | -2,144.77%-17.07M | 169.18%581.87K | 4,286.96%834.93K | 180.18%216.17K |
| Earning before tax | 75.80%-68.22M | -92.19%-401.2M | -304.69%-281.86M | 11.73%-208.75M | -845.56%-69.65M | -132.94%-236.5M | -101.79%-7.37M | 155.14%717.87M | 262.86%411.51M | -268.64%-1.3B |
| Tax | -76.64%5.91M | -12.88%34.95M | 91.39%25.31M | -12.38%40.12M | 173.04%13.22M | 21.53%45.79M | 70.82%-18.1M | 194.08%37.68M | -114.48%-62.03M | 79.00%-40.05M |
| After-tax profit from continuing operations | 75.71%-62.31M | -117.19%-366.25M | -354.68%-256.55M | 11.58%-168.63M | -121.55%-56.43M | -125.24%-190.7M | -107.29%-25.47M | 755.55M | 313.65%349.48M | 0 |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.34B |
| Earning after tax | 75.71%-62.31M | -117.19%-366.25M | -354.68%-256.55M | 11.58%-168.63M | -121.55%-56.43M | -125.24%-190.7M | -107.29%-25.47M | 156.30%755.55M | 313.65%349.48M | -330.85%-1.34B |
| Minority profit | 192.80%7.89M | 146.59%15.2M | -46.55%-8.51M | 7.87%-32.62M | 57.56%-5.81M | -269.56%-35.4M | -432.12%-13.68M | -464.52%-9.58M | -15.58%4.12M | -128.51%-1.7M |
| Profit attributable to shareholders | 71.70%-70.2M | -180.46%-381.44M | -390.01%-248.05M | 12.42%-136.01M | -329.42%-50.62M | -120.30%-155.3M | -103.41%-11.79M | 157.08%765.13M | 333.83%345.36M | -332.94%-1.34B |
| Basic earnings per share | 71.15%-0.15 | -179.31%-0.81 | -372.73%-0.52 | 12.12%-0.29 | -450.00%-0.11 | -120.37%-0.33 | -102.74%-0.02 | 157.24%1.62 | 329.41%0.73 | -331.97%-2.83 |
| Diluted earnings per share | 71.15%-0.15 | -179.31%-0.81 | -372.73%-0.52 | 12.12%-0.29 | -450.00%-0.11 | -120.37%-0.33 | -102.74%-0.02 | 157.24%1.62 | 329.41%0.73 | -331.97%-2.83 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants Limited (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants Limited (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants Limited (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants Limited (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.